Tinavi Medical Technologies Co Ltd (688277) — Capital Reinvestment Ratio
Tinavi Medical Technologies Co Ltd (688277) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.50 Million) in capital expenditures (CN¥928.31K). See how much free cash does Tinavi Medical Technologies Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tinavi Medical Technologies Co Ltd Capital Reinvestment Ratio (2015–2019)
This chart tracks Tinavi Medical Technologies Co Ltd's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd (2015–2019)
Year-by-year Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd from 2015 to 2019. For live market cap and broader valuation context, see 688277 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.98x | CN¥20.53 Million | CN¥20.17 Million | ▼ -52.8% |
| 2018 | 2.08x | CN¥13.15 Million | CN¥27.36 Million | ▲ +89.9% |
| 2017 | 1.10x | CN¥5.73 Million | CN¥6.28 Million | ▲ +2709.1% |
| 2015 | 0.04x | CN¥41.82 Million | CN¥1.63 Million | — |